New York to Start Clinical Trials of Anti-Malaria Drugs for COVID-19
As the number of COVID-19 cases continues to rise across the U.S., many state authorities are trying anything they can to address the health crisis.
On Tuesday, the state of New York will begin two clinical trials of potential treatments for COVID-19: One will study the anti-malaria drug chloroquine, and the other, a combination of the related drug hydroxychloroquine and the antibiotic Zithromax.
New York Gov. Andrew Cuomo said during a press briefing that he remains optimistic about these drugs. The Food and Drug Administration gave the go-ahead to test chloroquine and hydroxychloroquine as potential COVID-19 treatments last week. However, other officials, including National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony Fauci, are far from optimistic that those drugs will prove effective against the novel coronavirus.
Source Fool.com